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Abbreviations 
MS
2
:  Tandem Mass Spectrometry  
MS/MS: Tandem Mass Spectrometry 
MS
3
: 3-Stage Mass Spectrometry (MS/MS/MS) 
ICR: Ion Cyclotron Resonance  
ROC: Receiver-Operator Characteristic  
CID: Collision-induced Dissociation 
FDR: False Discovery Rate 
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Summary  
 Improvements in ion trap instrumentation have made n-dimensional mass 
spectrometry more practical.  The overall goal of the study is to describe a model for making 
use of MS
2
 and MS
3
 information in mass spectrometry experiments.  We present a statistical 
model for adjusting peptide identification probabilities based on the combined information 
obtained by coupling peptide assignments of consecutive MS
2
 and MS
3
 spectra.  Using two 
data sets, a mixture of known proteins and a complex phosphopeptide-enriched sample, we 
demonstrate an increase in discriminating power of the adjusted probabilities, compared to 
models using MS
2
 or MS
3
 data only.  This work also addresses the overall value of generating 
MS
3
 data as compared to an MS
2
-only approach, with a focus on the analysis of 
phosphopeptide data.  
 
Introduction 
Advances in mass spectrometer design continue to propel proteomics research.  One 
of the most widely used mass analyzers for protein work has historically been the ion trap, 
and a large proportion of the data from current mass spectrometry-based proteomics 
experiments are generated on such instruments.  This trend continues with current generation 
„linear trap‟ instruments that are characterized by increased ion capacity and thus improved 
resolution and sensitivity (1,2).  Standard proteomics approaches are based on the predictable 
fragmentation of peptides in the collision cell of the mass spectrometer and the subsequent 
interpretation of the resulting spectra to infer amino acid sequence, referred to as tandem 
mass spectrometry (MS/MS or MS
2
) (3-7). In practice, however, acquired MS/MS spectra are 
often noisy, contain only a small number of fragment ions due to incomplete peptide 
fragmentation, or reflect unanticipated instrumental or chemical artifacts. As a result, in a 
typical analysis of MS/MS spectra generated in a large scale experiment, only a small fraction 
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of the spectra can be successfully interpreted and assigned a peptide sequence with high 
confidence (8,9).  
Newer instrumentation supports alternative techniques for data generation that have 
the potential to improve peptide and protein identification.  One such technique is 3-stage 
mass spectrometry (MS
3
), in which peptide ions in an ion trap or ICR mass spectrometer are 
subjected to an additional stage of isolation and fragmentation.  The faster acquisition times 
of newer linear trap instruments such as the LTQ provide the option of collecting MS
3
 spectra 
of abundant MS
2
 peaks with overall cycle times similar to those of normal MS/MS
2
 cycles on 
older 3D trap instruments.  As a result, a number of researchers are choosing to routinely 
collect MS
3
 spectra during LC-MS/MS runs which have the potential to provide additional 
information useful for peptide identification and characterization.  This is deemed particularly 
important in the case of proteins identified by single peptides (10, 11) and for the analysis of 
phosphopeptides, the spectra of which are frequently dominated by a major fragment ion 
representing neutral loss of the phosphate group from the precursor peptide.  Therefore, 
phosphopeptides have been analyzed by automated data-dependent triggering of MS
3
 
acquisition whenever the dominant neutral loss ion of the appropriate mass is detected in an 
MS
2
 spectrum (12-14).  Fragmentation of the neutral loss ion typically provides significantly 
increased structural information via increased peptide bond cleavage.  Similar approaches 
may be applied to other major neutral loss ions (e.g. loss of 64 Da from peptides containing 
methionine sulfoxide) and to excessive prolyl- or aspartyl-directed fragmentation.  MS
3
 
spectra have proven to be useful in top-down analysis as well, both for protein identification 
and for characterization of specific sites of post-translational modification. (15, 16) 
 Generally speaking, there are several ways of combining MS
2
 and MS
3
 spectra from 
the same peptide to improve peptide identification.  One strategy involves integrating 
matching MS
2
 and MS
3
 spectra directly at the spectrum level, generating an “intersection 
spectrum” that contains only one type of ion, thus allowing simplified de novo sequencing of 
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the peptide. This approach has been described by Zhang and McElvain, who demonstrated the 
technique‟s usefulness in protein sequencing (17).  Olsen and Mann describe a custom 
scoring algorithm for MS
3
 spectra: their final score for a peptide is the product of the Mascot-
generated MS
2
 and the custom MS
3
 score (11).   In glycoproteomics, it is frequently the case 
that MS
2
 and MS
3
 provide complementary structural information on a glycopeptide: 
information on the structure of side-chain carbohydrate moieties is generally obtained from 
the MS
2
 spectrum, while amino acid sequence information is more readily obtained in the 
MS
3
 (18).  In the top-down technique described by Zabrouskov et al (16), sequence tags are 
extracted from MS
3
 spectra using a de novo algorithm and used to complement correlated 
MS
2
 spectral data in a “hybrid” database search strategy, implemented in the ProSight PTM 
search engine (19).  
 Related to the problem of MS
2
-MS
3
 spectrum integration, de novo sequencing-based 
algorithms have been described for combining pairs of spectra corresponding to unmodified 
and modified versions of the same peptide, or pairs of spectra corresponding to the same 
peptide tagged with a light or heavy version of a labeling reagent (20-23). However, while de 
novo sequencing approaches are promising, no computational tools are currently available 
that can be robustly applied in a high throughput environment.  As a result, analysis of MS
2
 
and MS
3
 data is still largely carried out with a conventional database search approach using 
commercially available programs such as SEQUEST, MASCOT, SpectrumMill, Phenyx, 
Paragon, or open source programs X! Tandem, OMMSA, Inspect, or ProbID (24-29).     
 While all existing database search tools can be used to identify peptides from both 
MS
2
 and MS
3
 spectra, automated analysis of those different types of spectra may not be 
identical. This often leads to the requirement that MS
2
 and MS
3
 spectra be separated for 
processing.  The main reason for this is that the measured precursor mass associated with 
MS
3
 spectra will not always correspond to the mass of an appropriate database peptide 
calculated using the same conventional rules that are applied in the case of MS
2
 spectra.  For 
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example, in phosphopeptide analyses variable modifications of -18 Da due to loss of 
phosphoric acid from S or T residues need to be specified for MS
3
, while the normal +80 Da 
phosphorylation modification on S, T, and Y are used for MS
2
.  It is computationally 
inefficient, and an unnecessary source of false positive identifications, to perform a combined 
search which permits both the -18 Da loss for MS
2
 spectra and the +80 Da addition for MS
3
 
spectra.  
 Searching MS
3
 spectra separately from their parent MS
2
 spectra essentially decouples 
the two sets of scans.  Intuitively, if analysis of successive MS
2
 and MS
3
 scans results in 
matching peptide sequences, there is an increased confidence in both identifications. The 
work described here attempts to provide a general, statistically sound assessment of the 
confidence achieved by combining the search results of MS
2
 and MS
3
 spectra from the same 
peptide. In contrast to aforementioned work, we assume a workflow in which the MS
2
 and 
MS
3
 spectra are searched independently using a common search engine (namely, SEQUEST 
in this work) and are independently statistically validated using PeptideProphet. We then re-
couple matching consecutive MS
2
 and MS
3
 scans and adjust the peptide probabilities initially 
computed by PeptideProphet to account for the new “linked” MS2-MS3 information. We 
describe a model that produces an adjusted probability of peptide identification and 
demonstrate, using a data set of MS
2
 and MS
3
 spectra generated using a control protein 
mixture, that such a correction can be used to better discriminate between correct and 
incorrect database search results. We also investigate ways to combine the adjusted MS
2
 and 
MS
3
 probabilities to compute a single confidence measure for their corresponding unique 
peptide. We then further demonstrate the utility of our method using a phosphopeptide-
enriched data set generated from D. melanogaster samples on an LTQ linear ion trap 
instrument. Finally, we compare runs in which both MS
2
 and MS
3
 spectra are generated with 
an MS
2
-only method to address the overall benefit of generating MS
3
 data.  
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Experimental Procedures 
Sample Preparation and Mass Spectrometry 
Two experimental data sets of MS/MS spectra were used in this work to evaluate the 
statistical model and to investigate its utility in the analysis of phosphopeptide-enriched 
samples. All spectra were acquired using an electrospray ionization (ESI) linear ion trap 
tandem mass spectrometer (Thermo Electron‟s LTQ). 
(1)  Nine-Protein Mix (“9-Mix”) sample. A mixture of nine commercially available protein 
standards-- P68082, myoglobin of Equus caballus (horse); P00698 Lysozyme C precursor of 
Gallus gallus (Chicken); Q29443 Serotransferrin precursor (Transferrin) of Bos Taurus; 
P18915 Carbonic anhydrase 6 precursor of Bos taurus (Bovine); P12763, Alpha-2-HS-
glycoprotein precursor (Fetuin-A) of Bos taurus (Bovine); P02754 Beta-lactoglobulin 
precursor (Beta-LG) of Bos taurus (Bovine); P62894 Cytochrome C of Bos taurus (Bovine); 
P02666 Beta-casein precursor of Bos taurus (Bovine); P02769 Serum albumin precursor 
(BSA) of Bos taurus (Bovine)-- was digested using trypsin and the resulting peptide mixtures 
were purified using reverse phase chromatography prior to mass spectrometric analysis. For 
the analysis of the peptides using mass spectrometry see “Mass spectrometry”.  The final data 
set consisted of three LC-MS/MS runs, with 58081 MS/MS spectra in total.  
(2) “Phosphopeptide sample”. This sample is a trypsin-digested, IMAC-enriched D. 
melanogaster whole cell lysate. The preparation of the phosphopeptide samples is described 
in detail in Bodenmiller et al. (30). Several mass spectrometry analyses of this sample were 
conducted, both for analysis of performance of the probability model and to test the value of 
generating MS
3
 data.   
Mass spectrometry: An LTQ quadrupole linear ion trap mass spectrometer (ThermoElectron, 
San Jose, CA) was used with a HP 1100 solvent delivery system (Agilent, Polo Alto, CA) for 
the analysis of the D. melanogaster Kc167 cells cytosolic phosphoproteome. Peptides were 
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loaded on a capillary (BGB Analytik, Böckten, Switzerland) reverse-phase C18 column (75 
μm i.d. and 11 cm of bed length with Magic C18 AQ 5 μm 200Å resin (Michrom 
BioResources, Auburn, CA, USA)), and then eluted from the capillary column at a flow rate 
of 200-300 nl/min to the mass spectrometer through an integrated electrospray emitter tip. 
Peptides were eluted
 
for each analysis from 12% to 33% acetonitrile in which the ions were
 
detected, isolated, and fragmented in a completely automated
 
fashion.  The exact settings for 
MS
n
 acquisition were as follows: 
 9 protein mix: In the first scan event, all peptides eluting from the column were 
recorded in MS mode. The most intense ion was selected for product ion spectrum (MS
2
) in 
the second event. An MS
3
 spectrum of the most intense peak in the MS
2
 spectrum was 
automatically selected in the third scan event. The second and third events are then repeated 
two more times in the cycle, for the second and third most abundant MS
1
 ions, for a total 
cycle of seven events. A threshold of 5,000 ion counts was used for triggering an MS
2 
attempt. Wideband activation was enabled for all MS
2
 and MS
3
 scan events; MS
2
 isolation 
width was set to 2.0 m/z and MS
3
 isolation width was set to 4 m/z. For triggering an MS
3
 
event the most intense ion had to be above 50 ion counts. No further restrictions were made 
for the selection of the MS
3
 precursor.  
 Phosphopeptide sample: All peptides eluting from the column were recorded in MS 
mode in the first scan event. The most intense ion was selected for product ion spectrum 
(MS
2
) in the second event. An MS
3
 spectrum of the most intense peak in the MS
2
 spectrum, 
which for the phosphopeptide containing sample is in most cases the neutral loss peak (of 98 
Da) from a serine/threonine phosphopeptide, was automatically selected in the third scan 
event. These three events form one complete cycle.  A threshold of 20,000 ion counts was 
used for triggering an MS
2 
attempt. Wideband activation was enabled for all MS
2
 and MS
3
 
scan events. MS
2
 isolation width was set to 2 m/z and MS
3
 isolation width was set to 3 m/z. 
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For triggering an MS
3
 event the most intense ion had to be above 500 ion counts. No further 
restrictions were made for the selection of the MS
3
 precursor.  
 Phosphopeptide sample – additional data sets for comparison of MS2-only with 
MS
2
/MS
3
 methods: For the MS
2
/MS
3
 data set the data-dependent MS
n
 spectra were acquired 
as follows: in the first scan event, all peptides eluting from the column were recorded in MS 
mode, and then the most intense ion was selected for product ion spectrum (MS
2
) in the 
second event. In the third event a MS
3
 spectrum was triggered specifically in the event of a 
phosphate neutral loss (-98 Da for singly, -49 Da for doubly and -32.66 Da for triply charged 
peptides) in the MS
2
 event. The second and third events are then repeated two more times in 
the cycle, for the second and third most abundant MS
1
 ions, for a total cycle of seven events. 
For the MS
2
-only data set the data-dependent MS
n
 spectra were acquired as follows: in the 
first scan event, all peptides eluting from the column were recorded in MS mode, and then the 
three most intense ions were consecutively selected for product ion spectrum (MS
2
) for a total 
cycle of four events. Further settings for these samples were: wideband activation was 
enabled for all MS
2
 and MS
3
 scan events, MS
2
 isolation width was set to 2 m/z and MS
3
 
isolation width was set to 4 m/z. For triggering an MS
3
 event in the MS
2
/MS
3
 data set the 
most intense ion had to be above 50 ion counts. No further restrictions were made for the 
selection of the MS
3
 precursor.  
 
Database Searching and Results Analysis 
 MzXML files were generated from ThermoFinnigan *.raw files using the ReAdW 
tool available in the TPP platform (31-33).  MS
2
 and MS
3
 peaklist files in *.dta format were 
extracted separately from the mzXML files using mzXML2Other tool with the -level option
1
.  
For the 9-Mix data set, a custom fasta sequence file was constructed consisting of sequences 
                                                 
1
 http://tools.proteomecenter.org/software.php 
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corresponding to the proteins in the mixture and common contaminants appended to a 
reversed version of the IPI Human data set.  Resulting *.dta files for the 9-Mix data set were 
searched with SEQUEST using the following parameters:  peptide tolerance of 3.0 Da; b- and 
y-ion series; partial trypsin digestion, allowing for one missed cleavage site; a fixed 
modification of 57.02 was specified for Cysteine and a variable post-translational 
modification (PTM) of 16.0 to Methionine.  MS
3
 data sets were searched using identical 
parameters.  Note, partial trypsin specificity is required for searching MS
3
 spectra 
corresponding to the fragmentation of a selected y- or b-ion from the MS
2
 spectrum.  If 
sufficient computational resources are available, searching MS
2
 spectra allowing for partially 
tryptic peptides can often be beneficial and result in additional identifications. However, 
doing so requires that the results are properly analyzed with a tool that accommodates tryptic 
termini information in the statistical model, such as PeptideProphet.  In addition, a subset of 
MS
3
 spectra from this data set was also searched allowing for the C-terminus variable 
modification of -18.0 Da to accommodate the possibility that the MS
3
 precursor is a b-ion 
(11). The results indicated that including this modification does not significantly alter the 
overall performance; in fact, accommodating the variable modification decreases the number 
of identifications slightly (due to loss of a number of true peptide assignments because of 
increases in search space). Based on this, the C-terminal modification was not used in the 
final analysis of data presented in this manuscript. The resulting data set contained 76873 
peptide assignments, counting 2+/3+ duplicates: 48921 MS
2
 (554 singly charged, 24233 
doubly charged, and 24134 triply charged), and 27952 MS
3
 (4582, 11700, and 11670 singly, 
doubly, and triply charged, respectively).  Note that because of the charge state ambiguity (in 
the case of low mass accuracy data such as the data sets used in this work, the charge state of 
a multiple charged peptide ion cannot be reliable determined), most of the multiply charged 
spectra were searched twice, assuming 2+ or 3+ charge state.  Furthermore, due to a relatively 
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small number of singly charged MS
2
 spectra, all such spectra were left out of the subsequent 
analysis.  
 The database for the phosphopeptide-enriched samples consisted of all Drosophila 
melanogaster sequences exported from the UniProt database (34), 26311 entries total, to 
which the reversed set of sequences was appended. Parameters for the MS
2
 search were: 
peptide tolerance of 3.0 Da; partial trypsin digestion, one possible missed cleavage; fixed 
modification of 57.02 for Cysteine; variable modifications of 80 Da were specified for S, T, 
and Y; a maximum 4 PTMs per peptide. The MS
3
 spectra were searched with the same set of 
parameters except that variable modifications of -18 Da on S and T (instead of +80 Da) were 
specified to accommodate loss of phosphoric acid leading to a dehydroalanine or 
dehydrobuyric acid, respectively. SEQUEST database searching for the primary 
phosphopeptide data set (excluding the MS
2
/MS
3
 to MS
2
-only comparisons) resulted in 
28865 peptide assignments, counting 2+/3+ duplicates: 16647 MS
2
 (143 singly charged, 8483 
doubly charged, and 8021 triply charged), and 12218 MS
3
 (547, 5895, and 5776 singly, 
doubly, and triply charged, respectively).  
 The additional phosphopeptide-enriched data sets used for comparison of MS
2
/MS
3
 
and MS
2
-only methodologies consisted of the following number of peptide assignments 
following SEQUEST database searching-  Run 1 (A07_5205): 4915 MS
2
 assignments (95 
singly charged, and 2410 each of doubly and charged), and 1897 MS
3
 assignments (31 singly 
and 933 each doubly and triply charged); Run2 (A07_5206): 6450 MS
2
 assignments (126 
singly, 3162 doubly and triply charged); Run 3 (A07_5207): 4883 MS
2
 assignments (103 
singly charged, and 2390 each of doubly and charged), and 1879 MS
3
 assignments (43 singly 
and 918 doubly and triply charged); and Run 4 (A07_5208): 6403 MS
2
 assignments (159 
singly, 3122 doubly and triply charged). 
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Processing of MS
2
 and MS
3
 search results  
 Search results for each LC-MS/MS run were generated by first producing an html 
results file using the out2summary tool, exporting one result file for each MS level, for each 
run:  a total of six files for the 9-Mix data set and two files for the phospho data set.  Html 
results were then converted into pepXML format (31) using Sequest2XML. PeptideProphet 
(32) was run on each result set, generating probability scores for each search result that are 
added to the pepXML documents.. For the phospho data sets, PeptideProphet was run with 
the “-l” option, which results in alternate processing of DeltaCn scores marked with „*‟: 
results for which the top and second-highest ranked peptide assignment to a spectrum have 
homologous sequences (>70% sequence identity).  With this option on, PeptideProphet will 
use the Xcorr score of the first non-homologous lower scoring peptide match when 
computing DeltaCn score of the best scoring peptide. This option is beneficial in the event 
that the search returns several identical results that differ only by modification site for a 
sequence, as often occurs in phoshorylated peptide identifications.
2
  Resulting files were 
parsed and processed to generate all matching statistics using a custom set of scripts 
implemented in Python. Certain subsets of data were also exported into a local Mysql 
database instance to facilitate generation of specific statistics.   
 
Linking MS
2
 and MS
3
 scans and search results 
 The spectra in these experiments were generated in an interlaced manner, i.e. the scan 
cycle on the instrument followed the format: MS
1
->MS
2
->MS
3
->MS
2
->MS
3
->MS
2
->MS
3
, or 
MS
1
->MS
2
->MS
3
, with the MS
2
 scans triggered in a data dependent manner from the MS
1
, 
and the MS
3
 scans triggered from the preceding MS
2
. As a result, a set of “linked” MS2/MS3 
                                                 
2
 The default option in PeptideProphet is to set SEQUEST DeltaCn score to zero to reduce 
the probability that the best scoring peptide assignment to a spectrum is correct when the 
second best scoring peptide has high sequence homology.   
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scans were generated based on consecutive scan numbers. In the resulting data set, MS
2
 scans 
with no consecutive MS
3
 were retained and designated as linked, but as a link to a null MS
3
 
identification. MS
3
 scans without preceding MS
2
 scans should not occur physically, but do in 
these data for several reasons: namely, the corresponding MS
2
 peaklists that produced no 
database search result are typically not reported.  Also, some spectra containing only a few 
peaks may be filtered out by the data conversion software. The small number of instances in 
which these “orphaned” MS3 scans are generated invariably result in incorrect peptide 
identifications and are eliminated from subsequent analysis.   
 Due to uncertainty with the charge state each multiply charged scan was searched 
twice (in both 2+ and 3+ charge state), resulting in multiple search results for each scan. 
Consideration needs to be given to potential links between MS
2
 and MS
3
 search results for 
any pair of scan numbers. A +1 MS
2
 search result may only be linked to an MS
3
 search result 
that is +1, and a +2 MS
2
 scan may produce a link to a search result with either a +1 or +2 
charge state.  The double- and triple-charged SEQUEST search duplication, however, creates 
a situation in which a +3 MS
2
 search result may produce two possible links to +2 and +3 MS
3
 
search results for any pair of scan numbers. After generating all possible links, one pair of 
search results amongst all possible pairs for any two scan numbers (designated as the “unique 
pair”) is selected based on whether the sequences of the two peptide identifications 
composing a pair are matching.  Matching is defined here as whether or not the sequences are 
equal, or whether one contains a subsequence of the other.  For non-matching pairs, and scan 
sets with more than one pair with matching sequences, the match pair with the highest 
summed PeptideProphet probability is designated as the unique pair.  A schematic of all 
matching possibilities and selection of a unique pair is shown in Supplementary Figure 1. 
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Results and Discussion 
Overview of the probability adjustment method 
 The overall methodology for our approach is outlined in Figure 1.  Data generated by 
the mass spectrometer are processed via the Trans-Proteomic Pipeline (TPP) following 
normal procedures and using SEQUEST, Mascot, or X! Tandem database search tools for 
peptide identification (the tools currently supported by TPP), up through generation of 
peptide probabilities from PeptideProphet (32).  Analyses in this early stage of processing are 
conducted separately for MS
2
 and MS
3
 data.  To calculate an adjusted probability for all 
assignments, successive scans must be linked as described in the Methods section.  The 
multiple potential matches resulting from the charge state ambiguity are reduced in the 
processing, retaining only the most probable matching pair for any two scan numbers.  
 Based on the sequence of the highest scoring peptide produced by the database search 
tool for each scan, consecutive MS
2
/MS
3
 pairs may then be classified as to whether or not 
they match the same peptide sequence.  This classification forms the basis for the adjusted 
probability score (see below), which functions to reward assignments with matching 
sequences.  Only the top-ranked peptide sequence for each spectrum is used in this analysis; 
accommodation of lower ranking results, while potentially useful, is not considered for 
simplicity. The result of the probability correction procedure is a data set of linked MS
2
 and 
MS
3
 peptide identifications with adjusted probability scores.   
 
Linking MS
2
 and MS
3
 data: a case study of the 9-Mix data set 
 This analysis is carried out using a mixture of purified proteins (9-protein mix data 
set), in which it is possible to confidently label peptide identifications as „correct‟ or 
„incorrect‟. Because this data set was searched against a database consisting of the sequences 
of the mixture proteins appended with a much larger reversed human protein sequence 
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database, each spectrum could be assigned a correctness label based on whether the top 
SEQUEST hit for the spectrum was to one of the known protein entries.  The method used 
was simply to label as incorrect any assignment of a peptide from a known incorrect database 
entry (reversed human protein sequence entries in this case), whereas all assignments of 
peptides to one of the sample proteins can be considered correct (32).  
 The procedure begins by linking consecutive MS
2
 and MS
3
 scans using their scan 
numbers. The summary statistics of applying the linking procedure to the 9-Mix data set are 
shown in Table 1. Due to the uncertainty in the precursor charge state for LTQ spectra, for 
any pair of consecutive MS
2
/MS
3
 scan numbers, there may be one or two SEQUEST search 
results generated for each MS level, as described in Experimental Procedures. Consequently, 
an MS
2
 search result may be linked to more than one MS
3
 search result. For the 9-Mix data 
set, there are 16140 unique linked pairs in which the MS
3
 is not null.  Amongst these, eighty 
nine have MS
2
/MS
3
 charge states of +1/+1, eight of which match “correct” protein sequences 
in the database (either one or both of the sequences match).  For doubly-charged MS
2
 pairs, 
3761 are +2/+2 and 4043 are +2/+1, of which 878 and 2020 are correct, respectively.  For 
triply-charged MS
2
, +3/+3: 4020 pairs, 631 correct; +3/+2: 3777 pairs, 1177 correct; and 
+3/+1: 450 pairs, 111 of which are correct.  In all, linked pairs in which the MS
3
 has one less 
charge than the MS
2
 are more likely to be correct.  However, linked pairs for which the MS
3
 
is the same charge state as MS
2
 account for 36% of the correct identifications.   
 Neutral loss of amino acids from the N- and C-termini is a common phenomenon and 
has been described previously (35, 36). Selecting linked pairs in which both MS
2
 and MS
3
 
sequences are labeled correct and of the same charge state (+1/+1, +2/+2, and +3/+3) allows 
us to identify examples of amino acid neutral loss.  Our data confirms the conventional rules 
for amino acid neutral loss described in the literature.  Virtually all examples correspond to 
N-terminal loss of 1-4 amino acid residues, most frequently N-terminal to a proline.  276 out 
of 323 of the occurrences are doubly-charged, three are singly-charged, and the remaining 
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forty-four triply-charged.  Most examples occur multiple times:  in all there are one, thirty-
four, and nine unique neutral loss sequence examples for the singly-, doubly-, and triply-
charged cases, respectively.  These examples are provided in Supplementary Table 1.  
  After linking consecutive scans and selecting a unique linked pair, the peptide 
assignments are binned into sequence match categories dependent on whether a consecutive 
scan exists, and if so, whether the top-scoring SEQUEST sequence result of the successive 
scans match (Table 1b).  Sequence match categories (referred to as Match categories, or 
simply „Match‟ later in the text) are defined as follows: 0) no consecutive scan; 1) 
consecutive scans, but MS
2
 and MS
3
 sequences do not match; 2) consecutive scans, MS
3
 
sequence is a subset of the MS
2
 sequence; 3) consecutive scans, MS
3
 sequence identical to the 
MS
2
 sequence; and 4) consecutive scans, MS
2
 sequence a subset of MS
3
 sequence. In the data 
set of unique pairs, 69% of all MS
2
 spectra produced consecutive MS
3
 spectra (16140).  Out 
of those consecutive pairs, 1458 (9%) had matching sequences in which the MS
3
 sequence 
was a subset of the MS
2
 sequence.  116 MS
3
 spectra were orphaned because they did not have 
a preceding MS
2
 scan, and were discounted.  We note that there were no instances of identical 
sequence matches between MS
2
 and MS
3
 top-scoring hits in the 9-Mix data set, as may occur 
for neutral-ion events in which only a side-chain moiety is lost from the otherwise intact 
peptide backbone (e.g. a phosphate).  These losses are observed in other similar data sets, 
however, and do occur in the phospho-enriched data sets described later.   
 For a small number of linked pairs, the top-scoring MS
3
 sequence appears to be a 
superset of the MS
2
 sequence, binned as sequence match category 4.  Clearly such pairs are 
not physically possible. Detailed analysis indicated that that most of those cases can be 
explained as resulting from misidentification of the true peptide sequence from either MS
2
 or 
MS
3
 scan. For example, in some of these instances, the sequence corresponding to the +2 
MS
2
 is a subsequence of both the +3 MS
2
 sequence and the +2 MS
3
 sequence, with the +2/+2 
MS
2
/MS
3
 pair selected as the unique pair. In those cases, the peptide assignment to the +3 
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MS
3
 peaklist (with +3 being the true charge state of the peptide ion) scored lower than the 
assignment of a shorter peptide (a subsequence of the true peptide) to the +2 MS
3
 peaklist. 
Other examples involved cases of a high scoring assignment of a longer partially tryptic 
peptide sequence when the true peptide was a post-translationally modified tryptic peptide 
missed due to the restricted nature of the database search. Similarly, several cases were 
observed where an MS
3
 scan acquired on a doubly charged b-ion fragment from the parent 
MS
2
 spectrum resulted in a match of a longer sequence to the +3 MS
3
 peaklist, and no match 
in the case of the correct +2 charge state.  In any event, as can be seen from Table 1b, match 
category 4 represents a small number of special case instances.  For simplicity of articulation, 
this category is dropped from subsequent analysis. 
 Using the labeling of the data, the accuracies and sensitivities of the probability 
calculations could be determined.  Towards this end, each linked pair of spectra can also be 
assigned a truth category based on the correctness of the peptide assignments to the MS
2
 and 
MS
3
 scans.  The truth category is a label indicating whether neither, both, or which one of the 
matching scans has a „correct‟ label.  The total numbers of scans in each truth category are 
shown in Table 1c.  The number of unique pairs of search results in which both sequences 
were correctly assigned is 1509, corresponding to 6.4% of the total number of unique pairs of 
scans.  A greater number of linked pairs (3316 total, 14.2%) have either the MS
2
 only 
assigned correctly (2029), or only the MS
3 
(1287).    
 When comparing the counts in the sequence match category bins (Table 1b) with the 
truth category bins (Table 1c), there appear to be several (thirty four) more +/+ truth matches 
than expected from the number of entries in the sequence match bin categories 2 and 4.  
These entries are the result of sequence match category 1 entries contributing to the +/+ truth 
bin.  There are a number of cases in which the top-scoring MS
2
 and MS
3
 sequences both 
match one of the sample mix proteins, but the proteins are different or the match is to 
different peptides from the same protein.  Most of the instances are examples of the latter 
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case:  a homologous sequence in the protein TRFE_BOVIN results in two different peptides 
(CLMEGAGDVAFVK and KGDVAFVK) being identified in the joined pairs. One of the 
commercially obtained proteins in the mixture, TRFE_BOVIN, was also contaminated with 
the homologous TRFL_BOVIN, which exhibits 59% sequence identity.  As a result, 
homologous but not identical peptide sequences between the two proteins are identified in the 
joined pairs.  For four cases, however, even though both MS
2
 and MS
3
 identifications in the 
pair are labeled correct in that individually their sequences match one of the sample proteins, 
there is no similarity between the matching sequences.  These can be considered as chance 
matches to one of the sample mix proteins incorrectly labeled as correct (the observed 
number of such chance matches is consistent with the expected number given the relative 
sizes of the 9-Mix and the reversed Human protein sequence database).  In all of such cases, 
either the MS
2
 or the MS
3
 was a high-probability result with the other joined probability very 
low.  
 
Probability adjustment calculation  
 In automated analysis of mass spectrometry data, one of the most important tasks is 
the calculation of accurate and discriminative confidence measures for each peptide 
assignment to a spectrum produced by a database search tool. Towards that end, we seek to 
calculate a correction to the probability score that accommodates the increase in confidence 
resulting from matching MS
2
 and MS
3
 spectra.  The fact that matched consecutive MS
2
 and 
MS
3
 spectra are more likely to be correct forms the basis for adjusting the probabilities of 
these spectra. 
 Calculation of probabilities for each peptide assignment in the data set, performed 
independently for MS
2
 and MS
3
 data, represents the starting point in this analysis.  
PeptideProphet computes a probability for a peptide, designated here as p(+|D), by using the 
mixture model EM algorithm to model the distributions of various discriminant spectrum-
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level parameters, collectively represented here as D. The spectrum-level information D 
typically includes the discriminant database search score (a linear combination of the 
renormalized search scores reported by the database search tool used), the number of termini 
consistent with the specificity of the enzyme used to digest proteins, the number of missed 
internal cleavage sites, and the difference between the measured and the calculated precursor 
ion mass. In certain cases, additional parameters are included in the model such as the peptide 
pI value (37), or the presence of certain residues or sequence motifs in the sequence of the 
assigned peptide (e.g., the presence of a cysteine in the case of ICAT experiments, or NxS/T 
motif in the case of experiments employing glycopeptide-enrichment strategies).  
PeptideProphet probabilities are reasonably accurate for both MS
2
 and MS
3
 spectra.  A plot 
displaying probability accuracies of PeptideProphet results for the 9-Mix data is provided in 
Supplementary Figure 2.     
 The approach used to accommodate the additional sequence matching information is 
similar to the method described in (33) for adjusting probabilities to account for additional 
protein level information using the number of sibling peptides (NSP). The MS
2
/MS
3
 sequence 
match information is not available at the initial data analysis step, but can be used to adjust 
the initial probabilities p(+|D) after linking the corresponding MS
2
 and MS
3
 scans. Again, the 
adjustment is performed separately for MS
2
 and MS
3
 level data. Given the sequence match 
category (Match) assignments for all linked spectra, the adjusted probability of a linked 
peptide assignment from a certain sequence match category, p(+|D, Match), may be 
calculated as: 
                    
)|()|()|()|(
)|()|(
),|(



MatchpDpMatchpDp
MatchpDp
MatchDp              (1) 
where p(Match|+) and p(Match|-) represent the empirically derived probabilities of observing 
a peptide assignment in each Match category among all (MS
2
 or MS
3
) correct and incorrect 
peptide assignments in the data set, respectively.  Note that this calculation assumes that the 
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information derived from linking consecutive scans is independent of the identification 
information generated by a search engine. This is largely true. Normalized PeptideProphet 
SEQUEST discriminant score distributions for correct and incorrect peptide assignments to 
MS
2
 spectra of doubly charged precursor ions, plotted separately for peptide assignments to 
MS
2
 spectra belonging to different Match categories, are shown in Supplementary Figure 3; 
score distributions are similar for all values of Match parameter, justifying the assumption of 
the independence between the discriminant database search score and Match parameter. 
 The probability distribution p(Match|+)  may be calculated for each match category k 
as follows: 
                     



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where N is the total number of (MS
2
 or MS
3
) peptide assignments in the data set, and the sum 
is over all peptides i  in each Match category. The term p(Match|-) is calculated in a similar 
way. The overall proportion p(+) of correct assignment in the data set may be calculated as:  
                         
i
ii MatchDp
N
p ),|(
1
)(      (3) 
 The probabilities in Eq. 1, and the Match parameter distributions in Eq. 2, can be 
determined by starting with the initial PeptideProphet probability for each assignments, 
p(+|Di) and the overall proportion, p(+). The probabilities and Match distributions can then 
be updated in an iterative manner.  However, a single iteration was deemed to be sufficient 
for the data set used in this work.  
 
Application of the probability adjustment method to the 9-Mix data set 
 Table 2 lists p(Match|+) and p(Match|-) distributions calculated using Eq. 2 for the 9-
Mix data set for both MS
2
 and MS
3
 scans.  It can be seen that, in the case of MS
2
 spectra, a 
larger fraction of incorrect assignments have no consecutive matching scan.  For all instances, 
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the most likely sequence match category is category 1, corresponding to the case in which 
consecutive scans occur but with no matching sequence.  This is perhaps intuitive in the sense 
that it might frequently be the case that either the MS
2
 or the MS
3
 will produce an identifiable 
sequence, but not both.  The most obvious discriminating measure is the fact that for 30% of 
the correctly assigned MS
2
 spectra (the top row in the table), the linked MS
3
 spectrum was 
assigned a peptide sequence that is a subset of the MS
2
 sequence, as opposed to a 5% 
incidence for incorrect MS
2
 identifications.  If sequence matches are observed, identifications 
are thus much more likely to be correct; the same argument applies for MS
3
 scans preceded 
by MS
2
 scans.  Also noteworthy is the fact that for match category 1 pairs, the probability of a 
correct identification is less than the probability of an incorrect identification.  This will result 
in a probability penalty for consecutively linked scans without matching sequences.  The 
penalty is small in this case, much smaller than the boost due to a consecutive matching scan, 
but is nevertheless an effect of the model. 
 It should be noted that in addition to classifying peptide match pairs into bins as a 
function of sequence matching, they can also be classified into various precursor charge state 
pairs. Significant differences exist between the precursor charge state distributions of correct 
and incorrect matches. An expansion of the sequence match category probabilities into charge 
category bins is provided in Supplemental Figure 4 for each of the four posterior Match 
probability distributions of Table 2, as well as total counts of the number of matches falling 
into each bin for the 9-Mix data set. The charge state information would likely provide 
additional discriminative power. However, further subclassification of the data into charge 
state pairs requires larger amount of data and complicates the model. Thus, the charge state 
information has not been utilized in the model at this time.   
 An example of the probability adjustment procedure described above is illustrated in 
Figure 2a using a pair of matching scans from the 9-Mix data set.  MS
2
 spectrum 
A06_7233_c.18651.18651 is first paired to MS
3
 spectrum A06_7233_c_18652.18652 by 
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consecutive scan number. MS
2
 assigned peptide sequence 
TLNFNAEGEPELLMLANWRPAQPLK is then compared to MS
3
 sequence 
GEPELLMLANWRPAQPLK.  Since the MS
3
 sequence represents a fragment of the MS
2
 
sequence, the linked pair is assigned to sequence match category 2.  The adjusted 
probabilities are then calculated for each spectrum using Eq 1. In this instance, the initial 
PeptideProphet probability of 0.712 is adjusted to 0.995 for the MS
2
 spectrum, and 0.832 to 
0.989 for the MS
3
.  A combined probability may then optionally be calculated for the linked 
pair as a new discriminating measure, as discussed later in the text.   
 Also indicated in Figure 2 are examples of fragmentation patterns from other charge 
state pairs.  These examples are provided here to illustrate both differences in the relative 
extent of fragmentation that can occur as a function of charge and also the presence of 
redundant ions appearing in both the MS
2
 and MS
3
 spectra.  Panels 2b – 2d contain examples 
from the phospho data set, specific features of which will be discussed in more detail later in 
the paper. It should be noted that many identical ions can be observed between matching MS
2
 
and MS
3
 spectra. 
 In the development of the model, several (match category 2) cases were observed 
where both paired spectra had a low initial probability of being correct, but their probabilities 
became intermediate or even high values after adjustment. For example, the initial 
probabilities for peptide assignments to linked scans A06_7232_c.4362.4362.3 (MS
2
 scan), 
and A06_7231_c.4363.4363.2 (MS
3 
scan) of 0.077 and 0.319 would get boosted to 0.827 and 
0.830, respectively, if the probabilities were adjusted using the Match parameter distributions 
shown in Table 2. Boosting such low probability assignments may be undesirable regardless 
of their match category. To address this, several approaches were investigated, including 
introduction of probability-dependent match categories. A very simple constraint that worked 
well in the case of the 9-Mix data set was to avoid any probability adjustment for Category 2 
 23 
matches if both initial MS
2
 and MS
3
 probabilities were below a specified threshold, 0.5 in the 
case of these data.  This was an optional feature that was investigated using the 9-Mix data set 
but not utilized for the phosphopeptide data sets, as it was deemed a minor adjustment that 
did not significantly affect the overall results; specifically, the number of entries in the 9-mix 
data set that were affected by this exception was only 24 out of a total 23367 unique matches  
 The improved discriminatory power of the adjusted probabilities, calculated using the 
p(Match|+) and p(Match|-) distributions shown in Table 2 (after the empirical correction 
described above), is indicated in Figure 3, which shows Receiver-Operator Curves (ROC) for 
the data.  The performance of the model is evaluated separately for MS
2
 and MS
3
 spectra. The 
false positive error rate is plotted as a function of the sensitivity attainable by selecting a 
variable probability threshold.  Sensitivity in this case is defined as the ratio of the number of 
correct peptide assignments to MS
2
 (Figure 3a) or MS
3
 scans (Figure 3b) with a probability 
greater than or equal to a specific probability threshold and the total number of correct 
assignments to MS
2
 (4870) or MS
3
 (1256) spectra, respectively.  Similarly, the false positive 
error rate is calculated as the fraction of incorrect matches in the total number of spectra 
above each probability threshold. Note that there is redundancy between the MS
2
 and MS
3
 
peptide assignments, so summing the total possible number of correct peptide identifications 
from both MS
2
 and MS
3
 scans would not reflect the total number of unique identifications.   
 For both the MS
2
 and MS
3
 scans, the adjusted probability provides a better 
performance profile, achieving greater sensitivity at an equivalent error rate as compared to 
the initial data.  For example, at a 0.9 probability threshold, the initial MS
2
 probability results 
in the selection of 4072 correct peptide assignments at the expense of 67 incorrect ones. 
Using the adjusted probabilities, selecting the same number of correct identifications results 
in only 38 incorrect peptide assignments.. The improvement in MS
3
 discrimination is even 
more pronounced, especially in the optimal region of the curve. Using initial probabilities, 
1350 correct and 19 incorrect assignments to MS
3
 spectra pass the 0.9 threshold. Using the 
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adjusted probabilities, it becomes possible to select the same number of correct peptide 
assignments with the inclusion of only one false positive.    
 
Combining MS
2
 and MS
3
 probabilities 
 The result of the probability adjustment procedure described above is now two 
adjusted probabilities for each unique linked pair of scans, one each for MS
2
 and MS
3
.  
Possibilities for best utilizing both of these scores in selection of correct and incorrect 
identifications are now explored.  Ideally, a combined scoring approach would provide a 
greater discriminatory power for selecting correct and incorrect identifications than a 
subsequent counting of unique matches based on MS
2
 and MS
3
 taken individually.  Two 
possibilities for utilizing both scores are examined:   
                   )1)(1(1 32 MSMScomb ppP        (4a) 
                   32 ,maxmax MSMS ppP                               (4b) 
where pMS2 and pMS3 are the adjusted probabilities for the MS
2
 and MS
3
 scans, respectively, 
for the same linked pair.  The first option is appropriate when the two probabilities can be 
considered independent, and has been utilized (in a different context, i.e., for combining the 
evidence from different peptides) for the protein identification problem (33, 38).  Pcomb 
reflects the probability that at least one of the two peptide assignments, either to the MS
2
 or to 
the MS
3
 spectrum, is correct.  However, it is obvious that MS
2
 and MS
3
 spectra, and therefore 
the probability scores pMS2 and pMS3  of those spectra, are not fully independent measurements 
of a peptide in that identical ions will be measured in both spectra.  An alternative approach is 
to select the assignment with the highest probability, Pmax, thus reducing the likelihood of 
possible overestimation of the final probability.  Pmax has been used in other similar 
situations, e.g. in selecting amongst several alternative equivalent peptides (assignments of 
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the same peptide to multiple MS/MS spectra) in the ProteinProphet protein probability score 
(33), and in Mascot protein-level scoring (24).   
 Figures 4a and 4b show the results of counting the number of correct peptide 
assignments above specified probability thresholds, utilizing all possible scores calculated for 
a linked pair as the discriminating measure: initial MS
2
, initial MS
3
, adjusted MS
2
, adjusted 
MS
3
, Pmax, and Pcomb.  Displayed are the results on the set of all unique linked pairs.  A 
comparison of the initial and adjusted probability results for MS
2
 and MS
3 
again demonstrates 
an increase in the number of selectable correct peptide assignments at any probability 
threshold as a result of the probability adjustment.  Both Pmax and Pcomb scores perform 
similarly, and provide improved discrimination as compared to the individual measures.   
Obviously, the primary reason for the performance increase is the fact that the combined 
score permits the possibility of selecting either the MS
2
 or the MS
3
 for any linked pair, thus 
permitting a pair to be selected as correct if either probability is above threshold.  At the 99% 
probability threshold, for example, the adjusted MS
2
, adjusted MS
3
, Pmax and Pcomb 
probabilities correspond to 3141, 1050, 3775, and 3807 correct peptide identifications, 
respectively.  Figure 4c provides a measure of the rate of false-positives on these data for the 
most interesting thresholds.  The same performance trends are evident:  including roughly 40 
false positives, specifically 40, 41, 39, and 39 for adjusted MS
2
, adjusted MS
3
, Pmax, and Pcomb 
measures, respectively, results in selection of 1806, 4139, 4594, and 4762 correct 
identifications.  In all, Pcomb provides the most discriminative measure. 
 In addition to analyzing the discriminative power of computed probabilities, one must 
also assess their accuracy.  Probability accuracy plots for the adjusted and combined measures 
are shown in Fig 4d.  The adjusted probability scores still provide an accurate representation 
of true probabilities and fit the 45° line well.  The Pcomb and Pmax measures perform similarly 
well.  Interestingly, Pcomb does not overestimate probabilities as one might expect given the 
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dependence of MS
2
 and MS
3
 level spectra on this data set.  Additional analysis would be 
necessary to determine if this is a general characteristic.   
 
Phosphopeptide data set results 
 One of the main motivating factors in collecting MS
2
/MS
3
 data is to increase the 
confidence levels and the total number of phosphopeptide identifications. The identification 
of phosphopeptides from MS
2
 spectra is challenging because spectra recorded using an ion 
trap mass spectrometer often exhibit one or more dominant neutral loss peaks of 98 Da, 
whereas the occurrence and intensity of the other fragment ions (containing peptide sequence 
information) may be impaired. To investigate potential improvement in discrimination as a 
result of the probability adjustment on a phosphopeptide-enriched data set, a data set of MS 
spectra from a single LTQ injection of an IMAC-enriched D. melanogaster sample was 
selected for detailed analysis in this work. The data were acquired in a data-dependent mode, 
with MS
3
 scans triggered for the most abundant peak of the MS
2
 spectra which in the case of 
this sample mostly corresponds to the neutral loss peaks: -98.00 (-116.00), -49.00 (-58.00), -
32.60 (-36.66) Da from the precursor, as explained in the Experimental Procedures section.  
Since the sample in this case is a complex protein mixture, a precise labeling of peptide 
identifications as „correct‟ or „incorrect‟ is not possible.  Instead, only the composite false 
discovery rates (FDR) (a single measure for each filtering threshold) can be estimated by 
counting the number of matches to reversed sequences. 
 The methodology for generating adjusted probability scores for this data set is 
analogous to the 9-Mix data set.  Top-scoring MS
2
 and MS
3
 SEQUEST peptide assignments 
are linked based on consecutive scan numbers, and the top-scoring pair for consecutive scans 
is selected. Note that if MS
3
 spectra are triggered based on neutral loss peaks, charge state 
ambiguity between matching pairs can potentially be reduced.  This fact is not exploited in 
our analysis; rather, we maintain the same procedure for allowing all possible charge pairs in 
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a match. The match pairs are then classified into sequence match categories as described 
above. The same four sequence match categories are used: 0: no consecutive match; 1: 
consecutive match but no matching sequence; 2: matching sequences with MS
3
 sequence a 
subset of MS
2
 sequence; and 3: matching sequences with MS
3
 sequence identical to MS
2
.  In 
this data set, there were only two instances of scans that would correspond to the sequence 
match category 4: matching sequences with MS
2
 sequence a subset of MS
3
 sequence.  Again, 
this category was eliminated for simplicity.  We note that the additional constraints imposed 
by the data-dependent triggering of these data and the resultant database searching provisions 
would allow us to generate additional useful sequence match categories, corresponding to 
whether the site of modification of a match is identical between the two sequences.  We 
observed a number of instances in these data where the sequences matched but the sites of 
modification of the match did not, indicating ambiguity in the localization of the modified 
residues.  A larger data set would allow a more rigorous analysis of these types of results (39, 
40).      
 The number of search results generated for this data set is shown in Table 3a.  
SEQUEST searching produced 16647 and 12218 results for the MS
2
 and MS
3
 data sets, 
respectively, corresponding to 7547 unique matching pairs of searched results.  Counts for the 
four sequence match categories are shown in Table 3b.  Most significant is the fact that the 
sequence match category corresponding to neutral loss-only pairs (match category three) is no 
longer null; rather it is the more abundant category amongst the two representing matching 
sequences with 313 unique matches.   
 Corresponding posterior probabilities were calculated for the sequence match 
categories, and then used to calculate the final adjusted probability for each unique pair.  
These numbers are shown in Table 3c.  The frequencies of observing a correct or incorrect 
assignment to an MS
2
 scan with no matching MS
3
 sequence (match category one) are 
relatively close; only a small probability correction occurs for these instances.  MS
3
 category 
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one probabilities are penalized, as are MS
2
 instances that lack a corresponding MS
3
 result.  A 
probability boost is received for pairs in categories two and three, with a greater correction 
given to the latter.  
 Although a true sensitivity measure for these data is impossible, it is possible to 
evaluate the relative performance of the various probability measures by examining the 
number of reversed database matches.  The decoy database method is increasingly being used 
as an effective means of estimating false positive rates in database searching when other 
methods of error rates estimation cannot be readily performed (41, 42). At any given 
probability threshold, the number of matches to reversed sequences can be calculated and 
compared to the total number of peptide assignments above that threshold to derive an 
estimate of the FDR (42). A measure of the performance of the various model probabilities on 
these data is shown in Figure 5a.  The figure plots the estimated number of correct 
identifications as a function of FDR. These data are generated by ranking all peptide 
assignments in order of decreasing probability.  The number of assignments of peptides from 
the forward database (nf) having a probability equal or greater than the probability of the n
th
 
top-ranking reverse entry (nr) is counted, and the estimated false discovery rate is determined 
as nr/nf.  The estimated number of correct assignments is similarly measured as nf – nr. This 
analysis is done separately for each of the initial and adjusted probability measures: MS
2
 and 
MS
3
 initial and adjusted, as well as the combined probability measures Pcomb and Pmax.  A 
version of these data in table form is provided in Supplemental Table 2, which presents 
estimated false positive percentages and number of forward match counts for inclusion of 
one, two, five, ten, fifty, and one hundred reversed matches, as well as the number of those 
forward entries that are identified as containing phosphorylation sites.   
 As can be seen from Figure 5a, at equivalent false discovery rates, the adjusted 
probability measures for MS
2
 and MS
3
 data provide a small but distinguishable improvement 
in the number of correct entries that can be selected, particularly for MS
3
. The bigger benefit 
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of course comes with the combined Pcomb and Pmax scores, which provide a much higher 
selection rate of forward matches than the initial MS
2
 and MS
3
 probabilities.. For example, by 
filtering the data using Pmax instead of the initial MS
2
 probability it becomes possible to 
extract 203 more forward matching identifications without allowing any reverse database 
matches (1703 peptide identifications vs. 1499). At a roughly 5% FDR, the initial MS
2
 
probability estimates 1893 correct peptides whereas the Pmax measure selects 2093.  It is 
interesting that Pcomb is much more discriminative than the Pmax probability measure on these 
data, selecting 2328 correct peptides at the 5% FDR. Overall, the acquisition of MS
3
 spectra 
does appear to increase the total number of phosphopeptide identifications by 10-25% in this 
data set, depending on the specific combined probability score used for comparison.  
 The results discussed above for this sample have focused on the total number of 
identifications, the majority of which are phosphopeptides. An equivalent plot of the results, 
but including only ranked non-phosphorylated identifications from the phosphopeptide data 
set, is shown in Figure 5b.  In general, the same trends can be seen; the model improves the 
assignment scores of unmodified peptides as well. 
 
Example MS
2
 and MS
3
 spectra from the phosphopeptide data set 
 In order to understand the underlying reasons for improved identification confidence, 
it is informative to briefly revisit the example shown in Figure 2.  These spectra are 
representative illustrations of matched MS
2
 and MS
3
 phospopeptide spectra of various 
precursor charge states. Several spectral features are of interest. Figure 2b shows an example 
of a +2/+1 match pair. The threonine in position three of the sequence matching the MS
2
 
spectrum is phosphorylated.  The large y12 peak corresponding to a fragmentation n-terminal 
to a double proline was selected by the instrument for MS
3
.  This is a general characteristic of 
the singly charge spectra corresponding to correct identifications in these data: the majority 
are proline-directed, with a Pro identified in the first position. Although the fragmentation is 
 30 
reasonable in this MS
3
 spectrum, a large fraction of singly-charged spectra exhibit poor 
fragmentation with one or two major peaks corresponding to Pro, Asp or occasionally Glu 
cleavage dominating.  This is not surprising due to the relatively low energy imparted to 
singly-charged ions via collision-induced dissociation (CID) in a trap instrument;  typically 
the most facile fragments are the most readily observable. As can be seen, many of the same 
ions occur in both spectra.  However, the shorter sequence and the absence of the 
phosphorylated residue in the MS
3
 simplify the spectrum and increases confidence in the 
identification. Figure 2c shows a +3/+1 phosphopeptide example.  +3/+1 instances are rarer 
than the +2/+1 (see Supplementary Figure 3), and the same trends occur.  The MS
3
 spectrum 
shown is a proline-directed fragmentation event, with Asp-directed fragmentation peaks 
dominating the spectrum.   
 Figure 2d is an example of a +2/+2 phosphopeptide ion. The peak selected for MS
3
 
corresponds to the doubly-charged y13 peak with a -98 Da loss of the phosphate moiety.  
Although many identical ions are identified in both spectra, there is a significant difference in 
the fragmentation pattern, with several ions observable in MS
3
 which are not readily 
observable in the MS
2
.  
 
Data set dependence of probability adjustment 
 Since the two primary data sets used in this work differ significantly in terms of 
sample complexity, it is also informative to compare these two data sets with respect to the 
MS
2
/MS
3
 matching statistics and the degree to which the initial peptide probabilities are 
adjusted to account for the sequence match information. The Match parameter distributions 
p(Match|+) and p(Match|-) vary between the data sets, reflecting the differences in the sample 
complexity and data set size. This is illustrated in Figure 6, which plots the logarithm of the 
ratio p(Match|+)/p(Match|–) for each match category k for both data sets. A ratio greater than 
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1 (log ratio greater than 0) indicates the region where the probabilities are boosted after 
adjustment for Match information, whereas a ratio less than 1 (log ratio below 0) indicates 
that the Match adjustment reduces the probability that a peptide assignment is correct.  While 
the overall trend is similar for both data sets, significant differences exist in the amount of 
adjustment. For example, the penalty applied to a peptide assignment to a MS
2
 spectrum with 
no subsequent MS
3
 spectrum (match category 0) is approximately twice as high in the case of 
the phosphopeptide enriched data set than in the 9-Mix data set.  On the other hand, the 
amount of probability boost for peptide assignments in the Match=2 category is higher in the 
case of the 9-Mix data set.  A better understanding of these results requires analysis of the 
MS
2
-MS
3
 linking statistics for a larger data set. However, it is clear that the amount of 
probability adjustment in each sequence match category is data set-dependent.  Thus, it is 
advantageous to use statistical methods for combining MS
2
 and MS
3
-level data that can learn 
the appropriate amount of probability adjustment from the data itself, such as the method 
presented in this work.    
 
Comments on the overall merit of generating MS
3
 data 
 This paper describes a method for utilizing MS
2
 and MS
3
 information for cases in 
which such data has been generated.  A fundamental question arises, however, as to whether 
or not the benefits of generating MS
3
 justifies the additional cycle time on the instrument, or 
whether the additional MS
2
 spectra that would be generating in that time would offset the 
potential advantage. It has recently been suggested (e.g. Ref 43) that the overall benefit of 
generating MS
3
 information for phopsphopeptide experiments may be limited. Although a 
comprehensive analysis of the merits of MS
3
 data generation is beyond the scope of this 
work, the situation is explored here by comparing sets of mass spectrometry runs on identical 
samples utilizing both methods: the MS
2
/MS
3
 cycle discussed above, and an MS
2
-only 
method.  
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 LC-MS/MS analysis was performed on two additional IMAC-enriched whole-cell D. 
melanogaster tryptic digests using a Thermo LTQ, as described in Experimental Procedures. 
Each sample was separated into two equal fractions which were run individually using the 
MS
2
/MS
3
 run method or the MS
2
-only method. MS
2
 and MS
3
 peaklists were extracted from 
the raw data file and searched separately using SEQUEST. Final SEQUEST reports were then 
combined into two final result sets for each pair of experiments, one set for the MS
2
/MS
3
, and 
one for the MS
2
-only data.  These four result sets were then analyzed using 
Peptide/ProteinProphet. 
 To compare results at both the peptide and protein levels, individual identifications for 
each of the two final result sets were grouped based either on unique peptide sequence or 
protein accession numbers. The union, intersection and differences between the MS
2
/MS
3
 and 
MS
2
-only runs were calculated. The results are displayed as Venn diagrams in Figure 7 for 
both pairs of experiments. Given that there was significant variation between the number of 
peptide and protein identifications of the same run method, the two pairs of experiments were 
not combined to reduce the effect of instrument sampling rate variability in peptide 
identification, providing a more fair assessment of differences between the two methods. The 
top pair of Venn diagrams indicate the number of unique proteins identified by each method. 
Proteins were included in a set if they participated in an identified protein group (see Ref 33) 
with a group probability of at least 0.95. Proteins from the same group (indistinguishable 
proteins given the sequences of identified peptides) were counted as a single entry. The lower 
set of Venn diagrams shows unique peptide identifications. Peptides were included in these 
sets if their modified sequences were unique, i.e. two peptides with any modification or 
sequence differences were considered two unique peptides for the main figure. 
PeptideProphet probability scores of 0.95 or above were required for inclusion.  Peptide 
uniqueness can be defined by a number of standards, however, and the number of 
identifications listed in each area of the Venn diagram may be overestimated depending on 
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the definition.  The break-out boxes for each of the peptide sets indicate the number for each 
region of the Venn diagram under four alternative definitions of peptide uniqueness.  Under 
the Type 1 definition, peptides identified from consecutive MS
2
 and MS
3
 scans that differ 
only by the loss of one or more phosphate groups on one of the residues (i.e., MS
3
 was 
triggered on the neutral loss) were considered identical and counted as one. Under the Type 2 
definition, peptides which differ at the N- or C-terminus by one or more amino acid residues 
(e.g., due to a missed cleavage) were considered identical, e.g.  
 FVS+80EGDGGHVKPTTF 
 FVS+80EGDGGHVKPTTFTMR 
 FVS+80EGDGGHVKPTTFTMRD 
where S+80 indicates a phosphorylated Ser residue. Under the Type 3 definition, peptides 
were counted as identical if they had the same sequence but the modification site was 
ambiguous (residues identified as being phosphorylated are within three amino acid 
sequences of each other), e.g.  
 KES+80NSEDELEYDPSLYPQR 
 KESNS+80EDELEYDPSLYPQR 
Under the Type 4 definition, peptides were counted as unique based on the sequence alone, 
e.g.: 
 KKES+80NS+80EDELEYDPSLYPQR 
 KKES+80NSEDELEYDPSLYPQR 
 KKESNS+80EDELEYDPSLYPQR 
 KKESNS-18EDELEYDPSLYPQR 
were considered identical sequences.  While these four definitions do not include all possible 
types and permutations that occur, using them to count peptides allows a more comprehensive 
comparison between the data sets. 
 The results indicate that for these data there are potential advantages to both 
techniques. At the protein level, the majority of proteins were identified by both methods. 
However, in one pair of runs the MS
2
-only method outperformed the MS
2
/MS
3
 method by 
identifying 42 more unique proteins than the MS
2
/MS
3
 method. At the peptide level, the 
MS
2
/MS
3
 method was able to identify more phosphorylated peptide forms in both sets of runs 
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under most of the criteria in which modifications were considered unique (Types 1-3). In 
terms of the number of unique peptides identified by sequence-alone (Type 4), not taking into 
account modification state, the MS
2
-only set identifies more peptides in one of the runs.  This 
suggests that, at least for certain conditions, sequence coverage may be better with the MS
2
-
only method.  
Overall, these results indicate that generation of MS
3
 data may result in a decrease in 
the number unique peptide and protein identifications. However, several additional comments 
are necessary for more objective evaluation of the benefits of acquiring MS
3
 data. First, the 
probabilities used in the comparison presented above (Figure 7) were the original 
probabilities generated by the PeptideProphet and ProteinProphet tools. The probability 
correction procedure described in this work should permit the selection of a greater number of 
peptides (and therefore proteins) at a fixed FDR, which would potentially mitigate the loss of 
sequence coverage. Furthermore if the goal of the study is to identify as many unique 
modification states as possible, MS
3
 data may improve the results. It should also be 
mentioned that the phosphopeptide data sets used in this work were of high quality (high 
degree of phosphopeptide enrichment), resulting in sufficiently strong intensity MS signal of 
phosphopeptide ions and relatively good MS
2
 fragmentation. On the other hand, it is possible 
that in other data sets (e.g., no or poor phosphopeptide enrichment), the relatively low 
abundance of phosphorylated peptides would lead to less intense MS signal and less 
interpretable MS
2
 spectra, thus making benefits of acquiring MS
3
 data more apparent.   
 
Concluding Remarks 
 The generation of MS
3
 information is common in directed areas of proteomics such as 
phosphopeptide identification.  Whether generation of MS
3
 information is the best strategy or 
not is partially dependant on the overall goals of the experiment. Data generated from a 
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complex phosphopeptide-enriched sample suggest that generation of MS
3
 spectra can 
potentially result in an increased number of unique phosphorylation site identifications.  On 
the other hand, the cycle time spent on generation of MS
3
 data does appear to detract from the 
overall number of unique peptides (by sequence only) and proteins identified in such an 
experiment. Also, although MS
2
 spectra in which neutral loss peaks are dominant are still 
observed in current generation trap instruments, these spectra appear to frequently contain 
better backbone fragmentation than older equivalents due to increased ion capacity of the 
trap.  Nevertheless, in experiments in which MS
3
 data have been generated, MS
2
/MS
3
 
matching information from the entire experiment can be used to adjust the probabilities of the 
individual peptide assignments, which has the effect of compensating for the reduced number 
of MS
2
 spectra.  
 In cases in which a very high certainty in a mapped phosphorylation site is needed, 
MS
3
 experiments are highly valuable as exemplified in the mapping of phosphorylation sites 
for which biological follow-up experiments are performed. Also, in cases in which neither 
measurement time nor the amount of phosphopeptide samples are limiting factors, the 
measurement of MS
3
 spectra is advantageous. In fact, in an experimental setup which aims to 
maximize the number of identified phosphorylation sites from a complex sample, one 
efficient strategy is to first perform MS
2
 experiments and then target specifically the 
unidentified phosphopeptide ions using MS
2
/MS
3
 measurements (44, 45). 
 Generally speaking, much of proteomics data analysis relies on the scores and 
probabilities produced by automated search algorithms. It is thus important that any 
probability measure is accurate, and makes use of all available information, particularly in 
situations where the targeted peptide identifications are rare, e.g. for phosphopeptides and/or 
when proteins are identified by a reduced number of peptides (such as an analysis in which N-
terminal peptides are enriched).  Here we have described methods for translating the 
additional information obtained by matching coupled peptide assignments to MS
2
 and MS
3
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spectra into a combined probability score, improving the ability to discriminate between true 
positive and false positive identifications.  We have demonstrated an increase in sensitivity 
and a corresponding decrease in the error rate of selecting correct identifications as a result of 
the adjusted probability using a mixture of known standard proteins, and applied the method 
to a complex phosphopeptide-enriched data set, demonstrating an improved discrimination 
between correct and incorrect peptide assignments for that sample.  
 The goal of this study was to describe a relatively simple but valid mechanism for 
adjusting probabilities of peptide identifications in scenarios in which standard database 
searching has been performed on MS
2
/MS
3
 data sets. An alternative computational strategy 
for accommodating MS
3
 information is to merge MS
2
 and MS
3
 spectra into a single spectrum 
prior to database searching.  Full investigation of the relative merits of pre-database search, 
spectral merging approaches versus a post-database search probability adjustment procedure 
such as the one discussed here is beyond the scope of this work, but is the subject of current 
investigation.  Other methodologies, such as merging spectra from differently charged 
precursors of the same peptide, could likely be utilized to improve peptide identification as 
well. 
 As instrumentation continues to improve the speed and accuracy of tandem MS 
measurements, the ability to generate complementary information such as MS
3
 spectra for any 
given ion will become increasingly practical.  Methods for accommodating this information 
are consequently useful, and can significantly improve the quality of the results generated by 
automated processing of mass spectrometry data.     
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  Data and Code Availability 
 MzXML and RAW datafiles, and processed unique linked pair data, for both the 9-
Mix and phospho samples are available online via the Tranche system 
(http://tranche.proteomecommons.org).  The software used in this work was developed in 
Python.  Python modules were implemented making use of the code library available with the 
InsPecT software package by the UCSD Computational Mass Spectrometry Research Group 
(28).  All code modules generated by our group for this project are available upon request. 
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Figure Legends 
Figure 1.  Overview of methodology.  MS
2
 and MS
3
 spectra are extracted from the raw data 
and the spectra are assigned peptides using sequence database searching (SEQUEST or 
similar programs). The resulting peptide assignments are statistically validated using 
PeptideProphet, which calculates for each assignment in the data set a probability of being 
correct (applied separately for MS
2
 and MS
3
 data). MS
2
 and MS
3
 scan results are correlated 
based on scan number, in which an MS
3
 spectrum is linked to an MS
2
 if its scan number is 
consecutive.  Based on the overall matched data set, a Bayesian probability correction is 
applied to linked scan results individually for MS
2
 and MS
3
 spectra, resulting in adjusted 
probability scores. In the final step, the MS
2
 and MS
3
 scan results are combined and a final 
probability calculated for each scan number as representative of the peptide identification.   
 
Figure 2. Examples of MS
2
/MS
3
 linked pairs and the probability correction procedure.  MS
2
 
(left) and matching consecutive MS
3
 peaklists (right) are shown.  The charge state of each 
spectrum is indicated in the upper left corner. a) Example of the probability correction for a 
+3 MS
2
 -> +2 MS
3
 matched pair.  b) A +2/+1 match pair for a phosphopeptide identification 
in which the y12 ion is selected for MS
3
. c) A +3/+1 identification; the y8 ion is selected for 
MS
3
.  d) An example of a +2/+2 loss of the phosphate moiety in which the most abundant 
MS
2
 peak selected for MS
3
 is the doubly-charged y13 – 98 Da. 
 
Figure 3. Performance of MS
2
 and MS
3
 scores with probability adjustment.  Error rate of 
MS
2 
a) and MS
3
 b) scores are shown as a function of sensitivity for initial (dashed) and 
adjusted (solid) probabilities.  Inserted panels are zoomed areas of the plots for the 0 - 10% 
error rate range.   
 
Figure 4.  Discriminating power and accuracy of computed probabilities.  a) Total number of 
correct peptide assignments is plotted as a function of minimum probability threshold for 
MS
2
 and MS
3
 spectra alone, both initial and adjusted, and both Pmax and Pcomb scores.  b) 
Same as a), zoomed in the region of minimum probability threshold 0.9 to 1.0.  c) Number of 
correct peptide assignments as a function of the number of incorrect assignments, plotted 
separately for MS
2
 (green) and MS
3
 (blue) initial (dashed) and adjusted (solid) probabilities, 
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as well as the combined Pmax (red) and Pcomb (purple).  d) Probability accuracy of the adjusted 
MS
2
, MS
3
, Pmax and Pcomb probabilities.   
 
Figure 5.  Performance of probability scores on the phosphopeptide data set.  The number of 
correct identifications estimated using the decoy database method is plotted as a function of 
FDR estimated using the decoy database search method.  a) Results for the phosphopeptide 
data set, and b) for the non-phosphorylated identifications only in the phosphopeptide data 
set.  For MS
2
 and MS
3
 results, dashed lines indicate initial and solid lines indicate corrected 
probability scores. 
 
Figure 6.  Degree of probability score adjustment by sequence match category for the 9-Mix 
and phosphopeptide data sets.  
 
Figure 7.  Comparison of MS
2
/MS
3
 and MS
2
-only experimental runs. Two equivalent pairs 
of runs are shown, labeled Run1 – Run4.  Venn diagrams display overlap between MS2/MS3 
(left) and MS
2
-only (right) data sets based on unique identifications at the peptide and protein 
levels. All identifications are based on a 95% probability threshold. The top diagrams display 
protein identifications based on unique Uniprot entry name.  The numbers represent the 
number of ProteinProphet protein groups that have a protein group probabilities equal or 
greater than 0.95. The lower diagrams show the same for peptide identifications based on 
peptide sequence, using initial PeptideProphet probability scores.  Peptide identifications with 
the least stringent, most inclusive uniqueness criteria are shown in the main figure.  Counts 
for each region of the diagram utilizing more stringent uniqueness criteria are shown in the 
boxes, labeled as “- Type”.  
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Table 1.  Results of consecutive MS
2
/MS
3
 scan pairing for the 9-Mix data set.  a) Overall pair 
counts. Total MS
2
/MS
3
 peptide assignments shows the number of identifications of the 
indicated type in the data set.  Number of unique pairs indicates the number of pairs generated 
by linking consecutive scan numbers and selecting the most likely pair amongst all 
possibilities.  MS
2
 search results without consecutive MS
3
 results are still counted in these 
numbers.  Panel b) shows the number of unique pairs for the MS
2
 and unique matching sets 
after binning into sequence match categories, as described in the text.  Panel c) shows truth 
category bin counts of the MS
2
 and unique matching sets.  A „+‟ in the truth category column 
descriptors indicates a correct match, „-‟ an incorrect, and „null‟ the lack of a consecutive MS3 
for an MS
2
 scan.  
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Table 2.  Posterior probabilities of observing a correctly (+) or incorrectly (-) assigned 
peptide to a MS
2
 or MS
3
 scan among peptides from the four most frequently observed 
sequence match categories in the 9-Mix data set (0: no consecutive scan; 1: consecutive scan, 
no matching sequence; 2: consecutive scan, MS
3
 sequence is a subset of MS
2
 sequence; 3: 
consecutive scan, MS
3
 sequence identical to MS
2
 sequence).  
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Table 3.  Statistics for the phosphopeptide-enriched data set.  a) Total match counts; b) 
Sequence match category counts; c) Posterior probabilities for the statistical model.  
Sequence match category numbers are described in the caption for Table 2. 
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